de Medina P - Search Results

1

A fast UPLC-HILIC method for an accurate quantiﬁcation of dendrogenin A in human tissues.

Soulès R, Audouard-Combe F, Huc-Claustre E, de Medina P, Rives A, Chatelut E, Dalenc F, Franchet C, Silvente-Poirot S, Poirot M, Allal B. Soulès R, et al. Among authors: de medina p. J Steroid Biochem Mol Biol. 2019 Nov;194:105447. doi: 10.1016/j.jsbmb.2019.105447. Epub 2019 Aug 12. J Steroid Biochem Mol Biol. 2019. PMID: 31415823

2

Synthesis, binding and structure-affinity studies of new ligands for the microsomal anti-estrogen binding site (AEBS).

Poirot M, De Medina P, Delarue F, Perie JJ, Klaebe A, Faye JC. Poirot M, et al. Among authors: de medina p. Bioorg Med Chem. 2000 Aug;8(8):2007-16. doi: 10.1016/s0968-0896(00)00119-x. Bioorg Med Chem. 2000. PMID: 11003145

3

Tamoxifen is a potent inhibitor of cholesterol esterification and prevents the formation of foam cells.

de Medina P, Payré BL, Bernad J, Bosser I, Pipy B, Silvente-Poirot S, Favre G, Faye JC, Poirot M. de Medina P, et al. J Pharmacol Exp Ther. 2004 Mar;308(3):1165-73. doi: 10.1124/jpet.103.060426. Epub 2003 Nov 14. J Pharmacol Exp Ther. 2004. PMID: 14617686

4

Molecular characterization of the microsomal tamoxifen binding site.

Kedjouar B, de Médina P, Oulad-Abdelghani M, Payré B, Silvente-Poirot S, Favre G, Faye JC, Poirot M. Kedjouar B, et al. Among authors: de medina p. J Biol Chem. 2004 Aug 6;279(32):34048-61. doi: 10.1074/jbc.M405230200. Epub 2004 Jun 2. J Biol Chem. 2004. PMID: 15175332 Free article.

5

Multiple targeting by the antitumor drug tamoxifen: a structure-activity study.

de Médina P, Favre G, Poirot M. de Médina P, et al. Curr Med Chem Anticancer Agents. 2004 Nov;4(6):491-508. doi: 10.2174/1568011043352696. Curr Med Chem Anticancer Agents. 2004. PMID: 15579015 Review.

6

Synthesis and biological properties of new stilbene derivatives of resveratrol as new selective aryl hydrocarbon modulators.

de Medina P, Casper R, Savouret JF, Poirot M. de Medina P, et al. J Med Chem. 2005 Jan 13;48(1):287-91. doi: 10.1021/jm0498194. J Med Chem. 2005. PMID: 15634023

7

The prototypical inhibitor of cholesterol esterification, Sah 58-035 [3-[decyldimethylsilyl]-n-[2-(4-methylphenyl)-1-phenylethyl]propanamide], is an agonist of estrogen receptors.

de Medina P, Boubekeur N, Balaguer P, Favre G, Silvente-Poirot S, Poirot M. de Medina P, et al. J Pharmacol Exp Ther. 2006 Oct;319(1):139-49. doi: 10.1124/jpet.106.104349. Epub 2006 Jul 11. J Pharmacol Exp Ther. 2006. PMID: 16835370

8

Insights into the cholecystokinin 2 receptor binding site and processes of activation.

Paillasse MR, Deraeve C, de Medina P, Mhamdi L, Favre G, Poirot M, Silvente-Poirot S. Paillasse MR, et al. Among authors: de medina p. Mol Pharmacol. 2006 Dec;70(6):1935-45. doi: 10.1124/mol.106.029967. Epub 2006 Sep 22. Mol Pharmacol. 2006. PMID: 16998007

9

Microsomal antiestrogen-binding site ligands induce growth control and differentiation of human breast cancer cells through the modulation of cholesterol metabolism.

Payré B, de Medina P, Boubekeur N, Mhamdi L, Bertrand-Michel J, Tercé F, Fourquaux I, Goudounèche D, Record M, Poirot M, Silvente-Poirot S. Payré B, et al. Among authors: de medina p. Mol Cancer Ther. 2008 Dec;7(12):3707-18. doi: 10.1158/1535-7163.MCT-08-0507. Mol Cancer Ther. 2008. PMID: 19074846

10

Signaling through cholesterol esterification: a new pathway for the cholecystokinin 2 receptor involved in cell growth and invasion.

Paillasse MR, de Medina P, Amouroux G, Mhamdi L, Poirot M, Silvente-Poirot S. Paillasse MR, et al. Among authors: de medina p. J Lipid Res. 2009 Nov;50(11):2203-11. doi: 10.1194/jlr.M800668-JLR200. Epub 2009 Jun 5. J Lipid Res. 2009. PMID: 19502590 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

56 results

Search Page